Internal Medicine, Gastroenterology · Henderson, NV
NPI
1962504126
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2839 Saint Rose Pkwy Ste 130
Henderson, NV, 89052
Phone (702) 558-4027
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
1,483 services
Medicare patients, 2024
603
Average age 74
Drug cost, 2024
$784K
1,926 prescriptions
Company payments, 2025
$88K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajat Sood was code 99214 (office e&m - established), 526 times for 324 patients. In total Rajat Sood billed 1,483 services in 30 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 526 | 324 | $88.53 | $47K |
| 99232 Hospital E&M - Subsequent | Facility | 178 | 81 | $59.75 | $11K |
| 99204 Office E&M - New | Office | 146 | 146 | $115.31 | $17K |
| 43239 Upper GI Endoscopy | Facility | 139 | 136 | $63.55 | $8,834 |
| 99213 Office E&M - Established | Office | 129 | 109 | $61.28 | $7,905 |
| 99223 Hospital E&M - Initial | Facility | 99 | 94 | $131.75 | $13K |
| 45378 Lower GI Endoscopy - Other | Facility | 63 | 63 | $123.31 | $7,769 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 41 | 40 | $170.42 | $6,987 |
| 43249 Upper GI Endoscopy | Facility | 36 | 35 | $111.21 | $4,004 |
| 45385 Colonoscopy - Lesion Removal | Facility | 25 | 23 | $179.51 | $4,488 |
| 45380 Lower GI Endoscopy - Other | Facility | 24 | 24 | $142.37 | $3,417 |
| 99203 Office E&M - New | Office | 17 | 17 | $66.97 | $1,138 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 17 | 17 | $177.43 | $3,016 |
By year: 2022 $183K for 1,737 services; 2023 $157K for 1,543 services; 2024 $140K for 1,483 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rajat Sood prescribed most often to Medicare patients was Pantoprazole Sodium, with 670 prescriptions and refills. In total Rajat Sood wrote 1,926 Medicare prescriptions that cost $784K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 670 | 1,837 | 305 | $6,135 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 373 | 394 | 364 | $64K |
| Sucralfate Generic | 112 | 272 | 62 | $7,021 |
| Omeprazole Generic | 103 | 297 | 47 | $1,069 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 78 | 78 | 75 | $1,218 |
| Dicyclomine Hcl Generic | 58 | 126 | 39 | $1,009 |
| Ursodiol Generic | 50 | 94 | 11 | $42K |
| Vemlidy Tenofovir Alafenamide | 41 | 49 | Under 11 | $78K |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 39 | 39 | 39 | $6,237 |
| Famotidine Generic | 29 | 83 | 13 | $125 |
| Cholestyramine Cholestyramine (With Sugar) | 26 | 49 | 13 | $2,599 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 22 | 22 | 22 | $300 |
| Tenofovir Disoproxil Fumarate Generic | 17 | 43 | Under 11 | $1,820 |
| Azathioprine Generic | 14 | 31 | Under 11 | $109 |
| Xifaxan Rifaximin | 14 | 14 | Under 11 | $45K |
Brand drugs: 608 claims; generic drugs: 1,318 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajat Sood $88K ($88K in general payments such as food, travel and fees) from 20 companies. The largest payer was Janssen Biotech, Inc. with $75K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 100 | $75K |
| Gilead Sciences, Inc. GILD | 15 | $11K |
| Abbvie Inc. ABBV | 21 | $529 |
| Phathom Pharmaceuticals, Inc. PHAT | 9 | $208 |
| Genzyme Corporation SNY | 14 | $190 |
| Madrigal Pharmaceuticals MDGL | 3 | $170 |
| Pfizer Inc. PFE | 11 | $164 |
| Intra-Sana Laboratories | 18 | $142 |
| Aimmune Therapeutics, Inc. | 3 | $72.03 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $68.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.